These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6180107)

  • 1. Elimination of polynucleotide-induced hyporeactivity in mice treated with interferon and antitumor therapy.
    Imanishi J; Kita M; Sugino S; Oku T; Kishida T
    J Interferon Res; 1982; 2(1):65-74. PubMed ID: 6180107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon counteracts pyrimidinone-induced hyporeactivity and the combined treatment has antitumor effect in mice.
    Oku T; Imanishi J; Kishida T
    Gan; 1984 Jul; 75(7):631-40. PubMed ID: 6205930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mouse interferon and polyriboinosinic acid-polyribocytidylic acid on L-cell tumor growth in nude mice.
    Clercq ED
    Cancer Res; 1977 May; 37(5):1502-6. PubMed ID: 856466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of polynucleotides on solid tumor produced in mice by Ehrlich ascites cancer cells.
    Nagano Y; Takano S
    J Interferon Res; 1982; 2(1):103-5. PubMed ID: 6180096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid.
    Stolfi RL; Martin DS; Sawyer RC; Spiegelman S
    Cancer Res; 1983 Feb; 43(2):561-6. PubMed ID: 6184150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon production linked to toxicity of polyriboinosinic acid-polyribocytidylic acid.
    De Clercq E; Stewart WE; De Somer P
    Infect Immun; 1972 Sep; 6(3):344-7. PubMed ID: 4564891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular alteration by interferon: a virus-free system for assaying interferon.
    Stewart WE; De Clercq E; De Somer P
    J Virol; 1972 Nov; 10(5):896-901. PubMed ID: 4344256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment.
    Emeny JM; Morgan MJ
    J Gen Virol; 1979 Apr; 43(1):253-5. PubMed ID: 113495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Production of the hyporeactivity factor by mouse cells].
    Sokolova TM; Gevorkian MG; Ershov FI
    Biull Eksp Biol Med; 1984 Sep; 98(9):329-30. PubMed ID: 6207869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice.
    Matsumoto T; Takahashi H; Shiva D; Kawanishi N; Kremenik MJ; Kato Y; Yano H
    Physiol Behav; 2008 Mar; 93(4-5):835-41. PubMed ID: 18191426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the priming effect of interferon in L cells. I. The primed interferon response and the kinetics of development of priming.
    Rosztóczy I
    Acta Virol; 1976 Dec; 20(6):472-8. PubMed ID: 13642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combination of different inducers on the refractory state in interferon production.
    Yershov FI; Tazulakhova EB; Novokhatsky AS
    Acta Virol; 1976 Feb; 20(1):15-22. PubMed ID: 7936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the production of bovine type I interferon on bovine embryonic lung cells by polyriboinosinic-polyribocytidylic acid.
    Rossi CR; Kiesel GK
    Am J Vet Res; 1980 Apr; 41(4):557-60. PubMed ID: 6157341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycoplasma-mediated hyporeactivity to various interferon inducers.
    Cole BC; Overall JC; Lombardi PS; Glasgow LA
    Infect Immun; 1975 Dec; 12(6):1349-54. PubMed ID: 1205616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor effect of fluoropyrimidines and polyinosinic-polycytidylic acid against L1210 leukemia.
    Iigo M; Chapekar MS; Glazer RI
    Cancer Res; 1985 Sep; 45(9):4039-42. PubMed ID: 2411395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly (I)-poly (C)], in children.
    Guggenheim MA; Baron S
    J Infect Dis; 1977 Jul; 136(1):50-8. PubMed ID: 328786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of the interferon protein: hyporesponsiveness.
    Stringfellow DA
    Tex Rep Biol Med; 1977; 35():126-31. PubMed ID: 358440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic liposome-mediated efficient induction of type I interferons by a low dose of poly I:poly C in mouse cell lines.
    Okamoto S; Watanabe Y; Takakura Y; Hashida M
    J Biochem; 1998 Oct; 124(4):697-701. PubMed ID: 9756612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC.
    Morgan ET
    Biochem Pharmacol; 1991 Jun; 42(1):51-7. PubMed ID: 2069598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.
    Stewart WE; De Clercq E; Billiau A; Desmyter J; De Somer P
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1851-4. PubMed ID: 4505664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.